Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy

被引：316

作者：

Nishino, Mizuki ^{[1
]}

Sholl, Lynette M. ^{[1
]}

Hodi, F. Stephen ^{[1
]}

机构：

[1] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 373卷 / 03期

关键词：

ADVANCED MELANOMA; SAFETY; NIVOLUMAB; TRIAL;

D O I：

10.1056/NEJMc1505197

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：288 / 290

页数：3

共 5 条

[1]

European Respiratory Society, 2002, Am J Respir Crit Care Med, V165, P277, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]

[2] Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial [J].

Rizvi, Naiyer A. ;

Mazieres, Julien ;

Planchard, David ;

Stinchcombe, Thomas E. ;

Dy, Grace K. ;

Antonia, Scott J. ;

Horn, Leora ;

Lena, Herve ;

Minenza, Elisa ;

Mennecier, Bertrand ;

Otterson, Gregory A. ;

Campos, Luis T. ;

Gandara, David R. ;

Levy, Benjamin P. ;

Nair, Suresh G. ;

Zalcman, Gerard ;

Wolf, Juergen ;

Souquet, Pierre-Jean ;

Baldini, Editta ;

Cappuzzo, Federico ;

Chouaid, Christos ;

Dowlati, Afshin ;

Sanborn, Rachel ;

Lopez-Chavez, Ariel ;

Grohe, Christian ;

Huber, Rudolf M. ;

Harbison, Christopher T. ;

Baudelet, Christine ;

Lestini, Brian J. ;

Ramalingam, Suresh S. .

LANCET ONCOLOGY, 2015, 16 (03) :257-265

[3] Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial [J].

Robert, Caroline ;

Ribas, Antoni ;

Wolchok, Jedd D. ;

Hodi, F. Stephen ;

Hamid, Omid ;

Kefford, Richard ;

Weber, Jeffrey S. ;

Joshua, Anthony M. ;

Hwu, Wen-Jen ;

Gangadhar, Tara C. ;

Patnaik, Amita ;

Dronca, Roxana ;

Zarour, Hassane ;

Joseph, Richard W. ;

Boasberg, Peter ;

Chmielowski, Bartosz ;

Mateus, Christine ;

Postow, Michael A. ;

Gergich, Kevin ;

Elassaiss-Schaap, Jeroen ;

Li, Xiaoyun Nicole ;

Iannone, Robert ;

Ebbinghaus, Scot W. ;

Kang, S. Peter ;

Daud, Adil .

LANCET, 2014, 384 (9948) :1109-1117

[4] Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab [J].

Topalian, Suzanne L. ;

Sznol, Mario ;

McDermott, David F. ;

Kluger, Harriet M. ;

Carvajal, Richard D. ;

Sharfman, William H. ;

Brahmer, Julie R. ;

Lawrence, Donald P. ;

Atkins, Michael B. ;

Powderly, John D. ;

Leming, Philip D. ;

Lipson, Evan J. ;

Puzanov, Igor ;

Smith, David C. ;

Taube, Janis M. ;

Wigginton, Jon M. ;

Kollia, Georgia D. ;

Gupta, Ashok ;

Pardoll, Drew M. ;

Sosman, Jeffrey A. ;

Hodi, F. Stephen .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (10) :1020-+

[5] Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer [J].

Topalian, Suzanne L. ;

Hodi, F. Stephen ;

Brahmer, Julie R. ;

Gettinger, Scott N. ;

Smith, David C. ;

McDermott, David F. ;

Powderly, John D. ;

Carvajal, Richard D. ;

Sosman, Jeffrey A. ;

Atkins, Michael B. ;

Leming, Philip D. ;

Spigel, David R. ;

Antonia, Scott J. ;

Horn, Leora ;

Drake, Charles G. ;

Pardoll, Drew M. ;

Chen, Lieping ;

Sharfman, William H. ;

Anders, Robert A. ;

Taube, Janis M. ;

McMiller, Tracee L. ;

Xu, Haiying ;

Korman, Alan J. ;

Jure-Kunkel, Maria ;

Agrawal, Shruti ;

McDonald, Daniel ;

Kollia, Georgia D. ;

Gupta, Ashok ;

Wigginton, Jon M. ;

Sznol, Mario .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2443-2454

← 1 →